Athero Review - Issue 1/2016
Guidelines
7
Statin-associated myopathy: clinical guideline of Slovak Atherosclerosis Association and Czech Society for Atherosclerosis
Daniel Pella, Anna Gvozdjáková, Ján Lietava, Jana Tisoňová, Katarína Rašlová, Branislav Vohnout (za Slovenskou Asociaci Aterosklerózy), Michal Vrablík, Vladimír Bláha, Renata Cífková, Richard Češka, Tomáš Freiberger, Pavel Kraml, Jan Piťha, Hana Rosolová, Vladimír Soška, Tomáš Štulc, Hana Vaverková, Zuzana Urbanová (za Českou Společnost Pro Aterosklerózu)
Reviews
19
Familial hypercholesterolemia: clinical reports, molecular genetics and differential diagnosis
Michal Vrablík, Lucie Schwarzová, Tomáš Freiberger, Lukáš Tichý, Richard Češka
28
What is the most important for patients with familial hypercholesterolaemia?
MedPed project in the Czech and Slovak
MedPed project in the Czech and Slovak
Michal Vrablík, Katarína Rašlová, Tomáš Freiberger, Richard Češka Katarína Rašlová, Branislav Vohnout
34
Turn in hypercholesterolemia treatment – PCSK9 inhibitors. What we know about the alirocumab (product Praluent®) yet?
Richard Češka, Lucie Votavová, Tanja Aleksičová
42
Athero Review
2016 Číslo 1
Najčítanejšie v tomto čísle
- Familial hypercholesterolemia: clinical reports, molecular genetics and differential diagnosis
- PCSK9 inhibitors in the management of patients with high cardiovascular risk – effective treatment to reach
- Turn in hypercholesterolemia treatment – PCSK9 inhibitors. What we know about the alirocumab (product Praluent®) yet?
- Statin-associated myopathy: clinical guideline of Slovak Atherosclerosis Association and Czech Society for Atherosclerosis